Safety and efficacy of weekly pemvidutide versus placebo for…
Weekly pemvidutide improved markers of liver inflammation and fibrosis in adults with fatty liver disease, offering hope for slowing liver damage progression.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A)…
A medication helped preserve muscle mass in people taking weight-loss drugs, suggesting a way to maintain strength during intentional weight reduction.
Underserved or high-risk populationsInterventions to reduce paediatric cancer treatment abandonment in…
Structured support programs cut childhood cancer treatment abandonment by roughly two-thirds in low- and middle-income countries, helping more children complete therapy.
Underserved or high-risk populationsRegional newborn screening for Gaucher disease in Kumamoto and…
Newborn screening identified Gaucher disease early, enabling long-term follow-up and earlier intervention for screen-detected children across varied disease presentations.
Near-term implementable findingSPROUT Guidelines for Molecular Profiling for Children with Solid Tumors
Expert consensus guidelines now standardize how doctors use genetic testing to guide treatment decisions in childhood solid tumors.